Protein Kinase C (19-31) (TFA)( PKC (19-31) (TFA) )

Catalog No. M29751 CAS No. ——

COA

Datasheet

HNMR

HPLC

MSDS

Handing Instructions

Group Booking Get Quotation Bulk Inquiry Add to Cart

Product Name

Protein Kinase C (19-31) (TFA)
Note

Research use only, not for human use.
Brief Description

Protein Kinase C (19-31) TFA, a peptide inhibitor of protein kinase C (PKC), derived from the pseudo-substrate regulatory domain of PKCa (residues 19-31) with a serine at position 25 replacing the wild-type alanine, is used as protein kinase C substrate peptide for testing the protein kinase C activity.
Description

Protein Kinase C (19-31) TFA, a peptide inhibitor of protein kinase C (PKC), derived from the pseudo-substrate regulatory domain of PKCa (residues 19-31) with a serine at position 25 replacing the wild-type alanine, is used as protein kinase C substrate peptide for testing the protein kinase C activity.
In Vitro

——
In Vivo

——
Synonyms

PKC (19-31) (TFA)
Pathway

Others
Target

Other Targets
Recptor

——
Research Area

——
Indication

——

CAS Number

——
Formula Weight

1657.84
Molecular Formula

C69H119F3N26O18
Purity

>98% (HPLC)
Solubility

——
SMILES

——
Chemical Name

Sequence:{Arg}{Phe}{Ala}{Arg}{Lys}{Gly}{Ala}{Leu}{Arg}{Gln}{Lys}{Asn}{Val}